Research Exchange

Digests

AI-collated, expert-reviewed summaries of the latest open access gynecologic research. Each digest matches the areas of interest for patients, advocates, researchers, and clinicians, then validates findings against the broader literature. New voices and timely results surface here as the field moves.

Ovarian

2026

October 2026

This Month in Ovarian Cancer

October was a busy, wide-ranging month for ovarian cancer research. The strongest threads came from people living with the disease: a large quality-of-life analysis showed that adding olaparib maintenance did not make people feel worse, long-term results confirmed durable benefit from a targeted pill combination for low-grade serous ovarian cancer, and new reviews mapped out how to choose among the growing list of treatments for platinum-resistant disease. Researchers also looked hard at prevention and risk, from how surgeons handle risk-reducing surgery around the world to what the evidence…

Read digest: This Month in Ovarian Cancer

Uterine

2026

October 2026

This Month in Uterine Cancer Research

October brought a steady stream of uterine cancer research with a clear message: knowing the molecular type of an endometrial tumor now shapes nearly every decision, from surgery to immunotherapy. Two new reviews pulled together what each of the four main molecular groups means for prognosis and treatment, while new trial and real-world data added to the growing list of immunotherapy options for advanced or recurrent disease, including for people whose tumors do not have the mismatch repair deficiency that usually predicts the best response. Researchers also looked at life after treatment,…

Read digest: This Month in Uterine Cancer Research

Cervical

2026

October 2026

This Month in Cervical Cancer Research

October was a busy month for cervical cancer research, and the work stretched across the full arc of care, from the first HPV vaccine dose to life after treatment. The biggest threads were a fresh pooled analysis confirming that adding immunotherapy to chemotherapy helps people with recurrent or metastatic disease live longer, new evidence that HPV-based screening can be safely simplified (including for women vaccinated as adolescents), and a cluster of studies on making radiation treatment gentler and more precise. Prevention research remained strong and global: teams in Kenya, Cameroon,…

Read digest: This Month in Cervical Cancer Research

Digests

This Month in Ovarian Cancer

This Month in Uterine Cancer Research

This Month in Cervical Cancer Research

Digests

This Month in Ovarian Cancer

This Month in Uterine Cancer Research

This Month in Cervical Cancer Research

This Month in Vaginal & Vulvar Cancer Research

This Month in Vaginal & Vulvar Cancer Research